Alln-177: Clinical Trials

1 trial of Alln-177, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Terminated 1

Follow Alln-177: new trials by email Literature Review of Alln-177 trials Research Report on Alln-177

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Establishing the Safety and Efficacy of Reloxaliase in Patients With Enteric Hyperoxaluria
Reloxaliase, Placebo - Enteric Hyperoxaluria
Phase 3TerminatedAllena Pharmaceuticals922019-08-262022-06-10

Conditions studied

Hyperoxaluria (1)  ·  Kidney Calculi (1)

Sponsors

Allena Pharmaceuticals (1)

Countries

Austria (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Canada (1)  ·  Croatia (1)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  Mexico (1)  ·  Portugal (1)  ·  Romania (1)  ·  Russia (1)  ·  Spain (1)  ·  Switzerland (1)  ·  United Kingdom (1)

Top investigators

David Clark, MD (1)

NIH funding

2018 (1)